Loading…
Reported covered position: Legislative Director, Rep. Phil Roe; Legislative Assistant, Rep. Jeb Hensarling; Legislative Correspondent, Senator Rick Santorum; Staff Assistant, House Transportation and Infrastructure Committee.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Skin Substitute Access and Payment Reform Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician reimbursement for orthopedic procedures. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Act of 2025. Issues related to Medicare coverage for skin substitutes. Issues related to Medicare complexity adjustment in HOPD and ASC settings.
Skin Substitute Access and Payment Reform Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2026 · third_quarter · Q3
Issues related to Section 301 investigation on forced labor. Issues related to Section 301 investigation on excess capacity. Issues related to Section 232 investigation on medical devices. Issues related to the USMCA trade agreement. Issues related to US/UK Pharmaceutical Agreement.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician reimbursement for orthopedic procedures. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Act of 2025. Issues related to Medicare coverage for skin substitutes. Issues related to Medicare complexity adjustment in HOPD and ASC settings.
Source: Senate LDA
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Issues related to Medicare local coverage determinations for skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025. H.R. 6852 Advanced Wound Care and Regenerative Medicine Access and Reform Act. Issues related to APNRM on Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals.
Skin Substitute Access and Payment Reform Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Act of 2025. Issues related to Medicare local coverage determinations for skin substitutes. Issues related to APNRM on Ensuring Safety Through Domestic Security with Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals. Issues related to Medicare complexity adjustment in HOPD and ASC settings.
Advanced Wound Care and Regenerative Medicine Access and Reform Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Issues related to Medicare local coverage determinations for skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025. H.R. 6852 Advanced Wound Care and Regenerative Medicine Access and Reform Act. Issues related to APNRM on Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals.
Skin Substitute Access and Payment Reform Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician reimbursement for orthopedic procedures. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Act of 2025. Issues related to Medicare coverage for skin substitutes. Issues related to Medicare complexity adjustment in HOPD and ASC settings.
Skin Substitute Access and Payment Reform Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Issues related to Medicare local coverage determinations for skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025. H.R. 6852 Advanced Wound Care and Regenerative Medicine Access and Reform Act. Issues related to APNRM on Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals.
Skin Substitute Access and Payment Reform Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Act of 2025. Issues related to Medicare local coverage determinations for skin substitutes. Issues related to APNRM on Ensuring Safety Through Domestic Security with Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals. Issues related to Medicare complexity adjustment in HOPD and ASC settings.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to the base erosion and anti-abuse tax. Section 899 of the One Big Beautiful Bill Act, H.R.1.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to the base erosion and anti-abuse tax. Section 899 of the One Big Beautiful Bill Act, H.R.1.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule, Medicare hospital outpatient rule, and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025. S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician fee schedule issues related to pediatric tympanostomies. H.R. 1931 / S. 249, Access to Pediatric Technologies Act of 2025. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025.
Skin Substitute Access and Payment Reform Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician fee schedule issues related to pediatric tympanostomies. H.R. 1931 / S. 249, Access to Pediatric Technologies Act of 2025. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule, Medicare hospital outpatient rule, and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025. S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025.
Access to Pediatric Technologies Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician fee schedule issues related to pediatric tympanostomies. H.R. 1931 / S. 249, Access to Pediatric Technologies Act of 2025. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Skin Substitute Access and Payment Reform Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule, Medicare hospital outpatient rule, and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025. S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Skin Substitute Access and Payment Reform Act of 2025
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician fee schedule issues related to pediatric tympanostomies. H.R. 1931 / S. 249, Access to Pediatric Technologies Act of 2025. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Medical Device Shortage Reduction Act of 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act. Issues related to infection prevention following childbirth.
Medical Device Shortage Reduction Act of 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act. Issues related to infection prevention following childbirth.
Access to Pediatric Technologies Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Access to Pediatric Technologies Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Access to Pediatric Technologies Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Access to Pediatric Technologies Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Access to Pediatric Technologies Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Access to Pediatric Technologies Act of 2024
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Medical Device Shortage Reduction Act of 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to the Pandemic and All-Hazards Preparedness Act. Issues related to FDA inspections of manufacturing facilities. Issues related to medical device supply chains. H.R. 3807, Medical Device Shortage Reduction Act.
Medical Device Shortage Reduction Act of 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to FDA inspections of manufacturing facilities. Issues related to medical device supply chains. H.R. 3807, Medical Device Shortage Reduction Act.
Medical Device Shortage Reduction Act of 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to medical device supply chains. Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Inflation Reduction Act, provisions related to drug pricing CY 2023 Medicare physician fee schedule, issues related to skin substitutes
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 2617 - Consolidated Appropriations Act, 2023 (Sec. 4136) CY 2023 Medicare physician fee schedule, issues related to skin substitutes
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
Consolidated Appropriations Act, 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. FDA issues in HR. 2617 Consolidated Appropriations Act of 2023 (sec. 4136). Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Consolidated Appropriations Act, 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 2617 - Consolidated Appropriations Act, 2023 (Sec. 4136) CY 2023 Medicare physician fee schedule, issues related to skin substitutes
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Inflation Reduction Act, provisions related to drug pricing CY 2023 Medicare physician fee schedule, issues related to skin substitutes
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA: H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; and H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA, H.R.7667, Food and Drug Amendments of 2022, and S.4348, FDASLA Act of 2022. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA: H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; and H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
National Defense Authorization Act for Fiscal Year 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to procurement of medical technologies, H.R.7900, National Defense Authorization Act for Fiscal Year 2023 and S.4543, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 (NDAA).
National Defense Authorization Act for Fiscal Year 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to procurement of medical technologies, H.R.7900, National Defense Authorization Act for Fiscal Year 2023 and S.4543, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 (NDAA).
National Defense Authorization Act for Fiscal Year 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to procurement of medical technologies, H.R.7900, National Defense Authorization Act for Fiscal Year 2023 and S.4543, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 (NDAA).
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Inflation Reduction Act, provisions related to drug pricing CY 2023 Medicare physician fee schedule, issues related to skin substitutes
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 2617 - Consolidated Appropriations Act, 2023 (Sec. 4136) CY 2023 Medicare physician fee schedule, issues related to skin substitutes
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA: H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; and H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. Medical device shortage reporting provisions of S. 3799, PREVENT Pandemics Act and forthcoming MUDFA legislation.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. FDA issues in HR. 2617 Consolidated Appropriations Act of 2023 (sec. 4136). Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA, H.R.7667, Food and Drug Amendments of 2022, and S.4348, FDASLA Act of 2022. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA: H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; and H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA, H.R.7667, Food and Drug Amendments of 2022, and S.4348, FDASLA Act of 2022. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to procurement of medical technologies, H.R.7900, National Defense Authorization Act for Fiscal Year 2023 and S.4543, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 (NDAA).
James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to procurement of medical technologies, H.R.7900, National Defense Authorization Act for Fiscal Year 2023 and S.4543, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 (NDAA).
James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to procurement of medical technologies, H.R.7900, National Defense Authorization Act for Fiscal Year 2023 and S.4543, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 (NDAA).
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 2356, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
Elijah E. Cummings Lower Drug Costs Now Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 2356, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.7127 (From 116th Congress) - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. S.4295 (From 116th Congress) - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
Protecting Access to Innovation During COVID–19 Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.7127 (From 116th Congress) - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. S.4295 (From 116th Congress) - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
Protecting Access to Innovation During COVID–19 Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
Protecting Access to Innovation During COVID–19 Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R. 2356, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act
Public Health Emergency Pass-Through Payment Fairness Act of 2020
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.7127 (From 116th Congress) - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. S.4295 (From 116th Congress) - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064 - Sunshine for Samples Act of 2019.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R.7127 - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. S.4295 - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.7127 H.R.8624 - Protecting Access to Innovation During COVID-19 Act S.4295 - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R.7127 - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. Issues related to Medicare telehealth coverage in the Centers for Medicare & Medicaid Services Interim Final Rule in response to the COVID-19 Public Health Emergency.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3780, HOME Act (Issues related to medical device supply chain reporting)
Protecting Access to Innovation During COVID–19 Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.7127 H.R.8624 - Protecting Access to Innovation During COVID-19 Act S.4295 - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
Preventing Essential Medical Device Shortages Act of 2020
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3780, HOME Act (Issues related to medical device supply chain reporting)
Issues related to post-market surveillance of medical devices and unique device identifiers. S.3780, HOME Act (Issues related to medical device supply chain reporting). Health, Economic Assistance, Liability Protection and Schools Act (Issues related to government procurement of medical technology).
Issues related to post-market surveillance of medical devices and unique device identifiers. S.3780, HOME Act (Issues related to medical device supply chain reporting). Health, Economic Assistance, Liability Protection and Schools Act (Issues related to government procurement of medical technology). FDA process for pre-approval inspections during COVID.
Public Health Emergency Pass-Through Payment Fairness Act of 2020
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.7127 H.R.8624 - Protecting Access to Innovation During COVID-19 Act S.4295 - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
Public Health Emergency Pass-Through Payment Fairness Act of 2020
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R.7127 - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. S.4295 - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
Issues related to U.S. subsidiaries of foreign companies in H.R.1., For the People Act of 2019.
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
S. 2543 - Prescription Drug Pricing Reduction Act of 2019. H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act. Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064 - Sunshine for Samples Act of 2019.
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Proposals related to biologics and drug pricing. Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064, Sunshine for Samples Act of 2019.
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
Proposals related to biologics and drug pricing. Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064, Sunshine for Samples Act of 2019.
Protect Medical Innovation Act of 2019
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019 Implementation of Tax Cuts and Jobs Act (P.L. 115-97.)
Protect Medical Innovation Act of 2019
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.2207 - Protect Medical Innovation Act of 2019. S.692 - Protect Medical Innovation Act of 2019. Issues related to Department of Treasury proposed regulation under IRC Section 382.
Protect Medical Innovation Act of 2019
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019
Protect Medical Innovation Act of 2019
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 2669, Medical Device Safety Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
S. 2543 - Prescription Drug Pricing Reduction Act of 2019. H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act. Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064 - Sunshine for Samples Act of 2019.
Prescription Drug Pricing Reduction Act of 2019
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
S. 2543 - Prescription Drug Pricing Reduction Act of 2019. H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act. Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064 - Sunshine for Samples Act of 2019.
Protect Medical Innovation Act of 2019
Client: SMITH & NEPHEW, INC. · Firm: SMITH & NEPHEW, INC.
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019 Implementation of Tax Cuts and Jobs Act (P.L. 115-97.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2026 · second_quarter · Q2
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Act of 2025. Issues related to Medicare local coverage determinations for skin substitutes. Issues related to APNRM on Ensuring Safety Through Domestic Security with Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals. Issues related to Medicare complexity adjustment in HOPD and ASC settings.
Issues related to Section 301 investigation on forced labor. Issues related to Section 232 investigation on medical devices. Issues related to the USMCA trade agreement.
Educate key government stakeholders on Smith+Nephew products applicable to the military and seek support for appropriations requests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2026 · first_quarter · Q1
Issues related to tariffs. Issues related to the USMCA trade agreement.
Educate key government stakeholders on Smith+Nephew products applicable to the military and seek support for appropriations requests.
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Issues related to Medicare local coverage determinations for skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025. H.R. 6852 Advanced Wound Care and Regenerative Medicine Access and Reform Act. Issues related to APNRM on Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2025 · fourth_quarter · Q4
Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Medicare physician fee schedule issues related to pediatric tympanostomies. H.R. 1931 / S. 249, Access to Pediatric Technologies Act of 2025. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2025 · third_quarter · Q3
Medicare physician fee schedule, Medicare hospital outpatient rule, and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025. S. 2561, Skin Substitute Access and Payment Reform Act of 2025.
Issues related to the base erosion and anti-abuse tax. Section 899 of the One Big Beautiful Bill Act, H.R.1.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2025 · second_quarter · Q2
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025.
Issues related to the base erosion and anti-abuse tax. Section 899 of the One Big Beautiful Bill Act, H.R.1.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2025 · first_quarter · Q1
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to pediatric tympanostomies. H.R. 1931 / S.249, Access to Pediatric Technologies Act of 2025.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2024 · fourth_quarter · Q4
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2024 · fourth_quarter · Q4
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2024 · third_quarter · Q3
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. H.R. 9157 / S.5275, Access to Pediatric Technologies Act of 2024.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Issues related to post-market surveillance of medical devices and unique device identifiers.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2024 · second_quarter · Q2
Education related to products applicable to the military.
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act. Issues related to infection prevention following childbirth.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2024 · first_quarter · Q1
Medicare physician fee schedule, issues related to skin substitutes. Policies related to facilitating access to pediatric medical technologies.
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act. Issues related to infection prevention following childbirth.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2023 · fourth_quarter · Q4
Issues related to medical device supply chains. Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 3807, Medical Device Shortage Reduction Act.
Consolidated Appropriations Act 2023, (Implementation of Sec. 4136), modifies the Medicare payment methodology for disposable negative pressure wound therapy devices. CY 2024 Medicare physician fee schedule, issues related to skin substitutes. Issues related to in-office reimbursement for tympanostomy products. CMSs proposed procedural notice on Transitional Coverage for Emerging Technologies (TCET). Issues related to Medicaid reimbursement for skin substitutes. Issues related to infection prevention following childbirth.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2023 · third_quarter · Q3
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Consolidated Appropriations Act 2023, (Implementation of Sec. 4136), modifies the Medicare payment methodology for disposable negative pressure wound therapy devices. CY 2024 Medicare physician fee schedule, issues related to skin substitutes. Issues related to in-office reimbursement for tympanostomy products. CMSs proposed procedural notice on Transitional Coverage for Emerging Technologies (TCET). Issues related to Medicaid reimbursement for skin substitutes. Issues related to infection prevention following childbirth.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2023 · second_quarter · Q2
Issues related to treatment of pressure injuries in Veterans Health Administration facilities. Education related to products applicable to the military.
Issues related to the Pandemic and All-Hazards Preparedness Act. Issues related to FDA inspections of manufacturing facilities. Issues related to medical device supply chains. H.R. 3807, Medical Device Shortage Reduction Act.
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2023 · first_quarter · Q1
Issues related to treatment of pressure injuries in Veterans Health Administration facilities. Education related to products applicable to the military.
Consolidated Appropriations Act 2023, (Implementation of Sec. 4136), modifies the Medicare payment methodology for disposable negative pressure wound therapy devices, including by establishing annual adjustments based on inflation and other factors. CY 2023 Medicare physician fee schedule, issues related to skin substitutes Issues related to in-office reimbursement for tympanostomy products.
Issues related to procurement of medical technologies. Education related to products applicable to the military.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2022 · fourth_quarter · Q4
Issues related to procurement of medical technologies, H.R.7900, National Defense Authorization Act for Fiscal Year 2023 and S.4543, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 (NDAA).
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 2617 - Consolidated Appropriations Act, 2023 (Sec. 4136) CY 2023 Medicare physician fee schedule, issues related to skin substitutes
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. FDA issues in HR. 2617 Consolidated Appropriations Act of 2023 (sec. 4136). Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2022 · third_quarter · Q3
Issues related to procurement of medical technologies, H.R.7900, National Defense Authorization Act for Fiscal Year 2023 and S.4543, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 (NDAA).
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Inflation Reduction Act, provisions related to drug pricing CY 2023 Medicare physician fee schedule, issues related to skin substitutes
Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2022 · second_quarter · Q2
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA, H.R.7667, Food and Drug Amendments of 2022, and S.4348, FDASLA Act of 2022. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
Issues related to procurement of medical technologies, H.R.7900, National Defense Authorization Act for Fiscal Year 2023 and S.4543, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 (NDAA).
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2022 · first_quarter · Q1
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. Medical device shortage reporting provisions of S. 3799, PREVENT Pandemics Act and forthcoming MUDFA legislation.
Issues related to procurement of medical technologies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2021 · fourth_quarter · Q4
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. Issues related to implementation of medical device shortage reporting requirement under Section 506J to the Federal Food, Drug, and Cosmetic Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2021 · third_quarter · Q3
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. Issues related to implementation of medical device shortage reporting requirement under Section 506J to the Federal Food, Drug, and Cosmetic Act.
H.R. 2356 and S.2363, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 5376 - Build Back Better Act, provisions related to drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2021 · second_quarter · Q2
H.R. 2356, the Better Wound Care at Home Act H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. FDA process for pre-approval inspections during COVID. Issues related to implementation of medical device shortage reporting requirement under Section 506J to the Federal Food, Drug, and Cosmetic Act.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2021 · first_quarter · Q1
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA. FDA process for pre-approval inspections during COVID.
H.R.7127 (From 116th Congress) - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. H.R.8624 (From 116th Congress) - Protecting Access to Innovation During COVID-19 Act. S.4295 (From 116th Congress) - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2020 · fourth_quarter · Q4
H.R.7127 H.R.8624 - Protecting Access to Innovation During COVID-19 Act S.4295 - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
Issues related to post-market surveillance of medical devices and unique device identifiers. S.3780, HOME Act (Issues related to medical device supply chain reporting). Health, Economic Assistance, Liability Protection and Schools Act (Issues related to government procurement of medical technology). FDA process for pre-approval inspections during COVID.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2020 · third_quarter · Q3
Issues related to post-market surveillance of medical devices and unique device identifiers. S.3780, HOME Act (Issues related to medical device supply chain reporting). Health, Economic Assistance, Liability Protection and Schools Act (Issues related to government procurement of medical technology).
Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R.7127 - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. S.4295 - Public Health Emergency Pass-Through Payment Fairness Act of 2020.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2020 · second_quarter · Q2
Issues related to post-market surveillance of medical devices and unique device identifiers. H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3780, HOME Act (Issues related to medical device supply chain reporting)
Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R.7127 - To amend title XVIII of the Social Security Act to make technical amendments to the separate payment under the Medicare program for disposable negative pressure wound therapy devices. Issues related to Medicare telehealth coverage in the Centers for Medicare & Medicaid Services Interim Final Rule in response to the COVID-19 Public Health Emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2020 · first_quarter · Q1
Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064 - Sunshine for Samples Act of 2019.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 748, CARES Act (Issues related to reporting of supply disruptions) H.R. 748, CARES Act (Issues related to the capacity of the health care system) S.3468, Preventing Essential Medical Devices Shortages Act H.R. 6062, To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes. S.3343 / H.R. 6049, Medical Supply Chain Security Act
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2019 · fourth_quarter · Q4
S. 2543 - Prescription Drug Pricing Reduction Act of 2019. H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act. Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064 - Sunshine for Samples Act of 2019.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices.
H.R.2207 - Protect Medical Innovation Act of 2019. S.692 - Protect Medical Innovation Act of 2019. Issues related to Department of Treasury proposed regulation under IRC Section 382.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2019 · third_quarter · Q3
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices.
Issues related to U.S. subsidiaries of foreign companies and the Foreign Agents Registration Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2019 · second_quarter · Q2
Issues related to U.S. subsidiaries of foreign companies and the Foreign Agents Registration Act.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices. H.R. 2669, Medical Device Safety Act.
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2019 · first_quarter · Q1
H.R.2207 - Protect Medical Innovation Act of 2019 S.692 - Protect Medical Innovation Act of 2019 Implementation of Tax Cuts and Jobs Act (P.L. 115-97.)
Issues related to U.S. subsidiaries of foreign companies in H.R.1., For the People Act of 2019.
Proposals related to biologics and drug pricing. Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2018 · fourth_quarter · Q4
Medicare Part D reimbursement proposals. Medicare Outpatient payment for skin substitutes. Implementation of disposable negative pressure wound therapy coverage established by "Consolidated Appropriations Act, 2016."
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act. H.R. 88, Retirement, Savings, and Other Tax Relief Act
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices, H.R. 2118, the Medical Device Servicing Safety and Accountability Act. Issues related to implementation of Title VII (device inspection and regulatory improvements) of the FDA Reauthorization Act (P.L. 115-52). Section 6111 of H.R. 6, the SUPPORT for Patients and Communities Act, issues related to CMS Open Payments System.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2018 · third_quarter · Q3
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices, H.R. 2118, the Medical Device Servicing Safety and Accountability Act. Issues related to implementation of Title VII (device inspection and regulatory improvements) of the FDA Reauthorization Act (P.L. 115-52). Section 6111 of H.R. 6, the SUPPORT for Patients and Communities Act, issues related to CMS Open Payments System.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2018 · second_quarter · Q2
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices, H.R. 2118, the Medical Device Servicing Safety and Accountability Act. Issues related to implementation of Title VII (device inspection and regulatory improvements) of the FDA Reauthorization Act (P.L. 115-52).
Issues related to Veterans Administration procurement.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2018 · first_quarter · Q1
Medicare Part D reimbursement proposals.
Issues related to Veterans Administration procurement.
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2017 · fourth_quarter · Q4
Issues related to Veterans Administration procurement.
H.R. 4617 (temporary moratorium on the medical device excise tax). Device tax provision in H.R. 1628, American Health Care Act of 2017 and proposed Senate amendments. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. H.R. 1, Tax Cuts and Jobs Act, provisions related to interest deductibility.
Medicare Part D reimbursement proposals. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2017 · third_quarter · Q3
Issues related to post-market surveillance of medical devices and unique device identifiers. Reauthorization of the medical device user fee agreement (H.R. 2430/S. 934, FDA Reauthorization Act of 2017), including policy issues related to FDA inspections reform (S. 404, H.R. 1736), 510(k) process (H.R. 2474, Medical Product Review Harmonization Act of 2017), and accessories (H.R. 2144, Risk-Based Classification of Accessories Act of 2017; S. 1070, Realizing Intended Safety for Certain Accessories Act of 2017.
Medicare Part D reimbursement proposals impacting low-income beneficiaries. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2017 · second_quarter · Q2
Issues related to post-market surveillance of medical devices and unique device identifiers. Reauthorization of the medical device user fee agreement (H.R. 2430/S. 934, FDA Reauthorization Act of 2017), including policy issues related to FDA inspections reform (S. 404, H.R. 1736), 510(k) process (H.R. 2474, Medical Product Review Harmonization Act of 2017), and accessories (H.R. 2144, Risk-Based Classification of Accessories Act of 2017; S. 1070, Realizing Intended Safety for Certain Accessories Act of 2017.
Device tax provision in H.R. 1628, American Health Care Act of 2017. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Section 385 Treasury Regulation. Proposals to reform the tax code, including the House Blueprint.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2017 · first_quarter · Q1
Medicare Part D drug rebate proposals. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
Issues related to post-market surveillance of medical devices and unique device identifiers. Reauthorization of the medical device user fee agreement, including policy issues related to FDA inspections reform (S. 404, H.R. 1736), 510(k) process, and accessories.
Device tax provision in H.R. 1628, American Health Care Act of 2017. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act.
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2016 · fourth_quarter · Q4
Issues related to post-market surveillance of medical devices and unique device identifiers. Combination Product Regulatory Fairness Act (S. 1767). 21st Century Cures Act (P.L. 114-255).
Medical device supply chain procurement at the Veterans Health Administration
S. 149, Medical Device Access and Innovation Protection Act H.R. 160, Protect Medical Innovation Act of 2015
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2016 · third_quarter · Q3
Medical device supply chain procurement at the Veterans Health Administration
S. 149, Medical Device Access and Innovation Protection Act H.R. 160, Protect Medical Innovation Act of 2015
Lobbying related to Medicare Part D drug rebate proposals. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2016 · second_quarter · Q2
Issues related to post-market surveillance of medical devices and unique device identifiers.
Lobbying related to Medicare Part D drug rebate proposals. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
S. 149, Medical Device Access and Innovation Protection Act H.R. 160, Protect Medical Innovation Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2016 · first_quarter · Q1
Education regarding hysteroscopic tissue removal. FDA's "Public Notification of Emerging Postmarket Medical Device Signals (Emerging Signals)." Issues related to post-market surveillance of medical devices and unique device identifiers.
Lobbying related to Medicare Part D drug rebate proposals. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
S. 149, Medical Device Access and Innovation Protection Act H.R. 160, Protect Medical Innovation Act of 2015
SMITH & NEPHEW, INC. via SMITH & NEPHEW, INC.
2015 · fourth_quarter · Q4
Lobbying related to Medicare Part D drug rebate proposals. Patient Access to Disposable Medical Technology Act (H.R. 1018; S. 1253) and similar provision contained in the 21st Century Cures Act (H.R. 6) and in the Consolidated Appropriations Act, 2016 (H.R. 2029).
Education regarding hysteroscopic tissue removal. Senate FDA innovation proposals, including 3rd party QMS certification program, 510(k) clearance process, "least burdensome" rules, and treatment of combination products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare physician fee schedule and Medicare Administrative Contractor policies, issues related to skin substitutes. Policies related to facilitating access to pediatric medical technologies.
Issues related to the Tax Cuts and Jobs Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to medical device sterilization and the use of ethylene oxide for sterilization under EPAs proposed regulations for the National Emission Standards for Hazardous Air Pollutants and the Federal Insecticide, Fungicide, and Rodenticide Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to FDA inspections of manufacturing facilities. Issues related to medical device supply chains. H.R. 3807, Medical Device Shortage Reduction Act.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to procurement of medical technologies. Education related to products applicable to the military.
Consolidated Appropriations Act 2023, (Implementation of Sec. 4136), modifies the Medicare payment methodology for disposable negative pressure wound therapy devices. CY 2023 Medicare physician fee schedule, issues related to skin substitutes. Issues related to in-office reimbursement for tympanostomy products. CMSs proposed procedural notice on Transitional Coverage for Emerging Technologies (TCET).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related to the Pandemic and All-Hazards Preparedness Act. Issues related to FDA inspections of manufacturing facilities. Issues related to medical device supply chains. Medical device shortage reporting.
Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to FDA inspections of manufacturing facilities. Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to reauthorization of MDUFA: H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; and H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes. Issues related to medical device supply chains. Medical device shortage reporting provisions of S.3799, PREVENT Pandemics Act and related to MDUFA bills.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Department of Treasury proposed regulation under IRC Section 382. Issues related to interest deductions under IRC section 163(j) of the CARES Act (P.L. 116-136). Issues related to the Further Consolidated Appropriations Act (P.L. 116-94).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Proposals related to biologics and drug pricing. Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064, Sunshine for Samples Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Proposals related to biologics and drug pricing. Implementation of disposable negative pressure wound therapy coverage established by Consolidated Appropriations Act, 2016. H.R. 2064, Sunshine for Samples Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act. S. 3274, CLEAN Act H.R. 6533, CLEAN Politics Act
Issues related to Veterans Administration procurement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
Medicare Part D reimbursement proposals. Medicare Outpatient payment for skin substitutes. Implementation of disposable negative pressure wound therapy coverage established by "Consolidated Appropriations Act, 2016."
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act.
Issues related to Veterans Administration procurement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
H.R. 4170 and S. 2039, Disclosing Foreign Influence Act. S. 2482, Foreign Agents Registration Amendments Act.
Medicare Part D reimbursement proposals. Medicare Outpatient payment for skin substitutes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Implementation of H.R. 1, Tax Cuts and Jobs Act. H.R. 195, Making further continuing appropriations for the fiscal year ending September 30, 2018, device tax provisions.
Issues related to post-market surveillance of medical devices and unique device identifiers. Issues related to third-party servicing of medical devices.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Issues related to post-market surveillance of medical devices and unique device identifiers.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
Device tax provision in H.R. 1628, American Health Care Act of 2017 and proposed Senate amendments. H.R. 184, Protect Medical Innovation Act of 2017. S. 108, Medical Device Access & Innovation Protection Act. Section 385 Treasury Regulation. Proposals to reform the tax code.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE
Medicare Part D drug rebate proposals. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
Filing targets: Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE
Lobbying related to Medicare Part D drug rebate proposals. Implementation of disposable negative pressure wound therapy coverage established by H.R. 2029, "Consolidated Appropriations Act, 2016."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to post-market surveillance of medical devices and unique device identifiers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE